Preprint · OA
via OpenAlex
The extracellular matrix protein fibulin-1 in idiopathic pulmonary fibrosis
UPT. Syiah Kuala University Library (Syiah Kuala University) · 2014
Abstract
One of the most pressing issues in the clinical management of patients with idiopathic pulmonary fibrosis (IPF) is how a clinician can respond when asked “how long do I have?” IPF has a varied clinical course and the only available treatments, aside from lung transplantation, are corticosteroids and immunosuppressants. The side effects of both corticosteroids and immunosuppressants may actually outweigh the benefits for use in IPF. Biomarkers of disease progression are often unable to predict acute lung function decline. This is possibly because the underlying mechanisms driving the disease are poorly understood and little attention has been paid to how intrinsic differences in resident lung fibroblasts may be contributing to this disease. In this thesis, extracellular matrix (ECM) molecules that are both found in the blood and released by resident lung fibroblasts were investigated for their utility as biomarkers of disease progression in IPF. The primary focus was on the ECM protein fibulin-1, an essential constituent of elastic fibres, which has not previously been studied in the context of interstitial lung disease. This thesis investigated the relationship between fibulin-1, and disease severity in patients with and without pulmonary fibrosis. In addition, the utility of fibulin-1 as a biomarker of disease progression was compared against other previously described components of the ECM, namely periostin, tenascin-C and fibronectin, in the same patients. Lastly, the effect of the profibrotic cytokine transforming growth factor-beta-1 (TGFβ1) on fibulin-1 levels in resident lung fibroblasts from patients with and without IPF was interrogated.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- Canonical
- link ↗
- Fetched
- 2026-10-24 MST
Cite this
APA
Jaffar, J. (2014). The extracellular matrix protein fibulin-1 in idiopathic pulmonary fibrosis. <em>UPT. Syiah Kuala University Library (Syiah Kuala University)</em>. https://openalex.org/W1517909036
Vancouver
Jaffar J. The extracellular matrix protein fibulin-1 in idiopathic pulmonary fibrosis. UPT. Syiah Kuala University Library (Syiah Kuala University). 2014.
BibTeX
@unpublished{jade2014Theext,
title = {The extracellular matrix protein fibulin-1 in idiopathic pulmonary fibrosis},
author = {Jade Jaffar},
journal = {UPT. Syiah Kuala University Library (Syiah Kuala University)},
year = {2014},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
International journal of molecular sciences 2025
Open access · OA
The Hypoxia-Retinoid Axis in Idiopathic Pulmonary Fibrosis: Multifaceted Etiology and Therapeutic Potential.
International Journal of Molecular Sciences 2025
Open access · CC-BY
The Hypoxia–Retinoid Axis in Idiopathic Pulmonary Fibrosis: Multifaceted Etiology and Therapeutic Potential
biorxiv 2024
Preprint · CC-BY
SOX9-regulated matrix proteins predict poor outcomes in patients with COVID-19 and pulmonary fibrosis
Frontiers in Pharmacology 2022
Open access · CC-BY
Idiopathic Pulmonary Fibrosis: An Update on Pathogenesis
The FASEB Journal 2020
Citation only
O‐GlcNAc Transferase Regulates Growth Factor Signaling and Extracellular Matrix Composition in Idiopathic Pulmonary Fibrosis
International Journal of Molecular Sciences 2020
Open access · CC-BY